featured
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JACC: Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT
JACC Heart Fail 2020 Dec 02;[EPub Ahead of Print], C Rapezzi, P Elliott, T Damy, J Nativi-Nicolau, JL Berk, EJ Velazquez, K Boman, B Gundapaneni, TA Patterson, JH Schwartz, MB Sultan, MS MaurerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.